Takeda undertakes major management reshuffle

1 April 2009

Japan's Takeda Pharmaceutical has carried out a major management reshuffle. Under the reorganization: Shigenori Ohkawa will become  chief  scientific officer and his role as general manager of the pharmaceutical  research division will be assumed by Hiroyuki Odaka; former chief  executive of Takeda North America Alan MacKenzie is now executive vice  president of international operations and will be replaced by Shinji  Honda; Tetsuo Miwa was promoted to general manager of the company's  chemistry manufacturing controls center; and Nancy Joseph-Ridge takes  over from Masaomi Miyamoto as general manager of the pharmaceutical  development division. Additionally, the firm is to appoint a chief  administrative officer at a later date.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight